The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-0231D).
 
David Michael Hyman
Consulting or Advisory Role - Chugai Pharma; Santa Maria Biotherapeutics
Patents, Royalties, Other Intellectual Property - Trovagene
 
Michael Sill
No Relationships to Disclose
 
Jonathan K Cho
No Relationships to Disclose
 
Heather A. Lankes
No Relationships to Disclose
 
Richard Piekarz
No Relationships to Disclose
 
Martee Leigh Hensley
Employment - Sanofi (I)
Consulting or Advisory Role - EMD Serono; Insys Therapeutics
Research Funding - Johnson & Johnson (Inst)
Patents, Royalties, Other Intellectual Property - author, Up to Date